EFFICACY AND SAFETY OF ANTI-TNFα HUMAN MONOCLONAL ANTIBODIES IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND SECONDARY RESISTANCE TO OTHER GENETICALLY ENGINEERED BIOLOGICAL AGENTS

• मुख्य लेखकों: E. I. Alexeeva (लेखक), T. M. Bzarova (लेखक), S. I. Valieva (लेखक), R. V. Denisova (लेखक), K. B. Isaeva (लेखक), A. M. Chomakhidze (लेखक), E. G. Chistyakova (लेखक), T. V. Sleptsova (लेखक), E. V. Mitenko (लेखक), N. I. Taibulatov (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: "Paediatrician" Publishers LLC, 2012-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Treatment of juvenile idiopathic arthritis (JIA) is one of the most important challenges in paediatric rheumatology. The results of the retrospective observational study of adalimumab (anti TNF human monoclonal antibodies) efficacy and safety in real clinical practice in treatment of 56 patients wit...